FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl
Expanded indications for the flutemetamol F18 injection include amyloid quantification and monitoring of anti-amyloid treatments.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2
In a second part of a new podcast episode on recently published research on projected radiation-induced cancers from computed tomography (CT) scans, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., offer current perspectives on cardiac CT dosing, AI advances and the importance of teamwork in ensuring appropriate dosing for CT.
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.
The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 1
In a new podcast, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., share their perspectives on recently published research looking at projections for future radiation-induced cancers from computed tomography (CT) scans.
‘I’m Telling You for the Last Time’ (Said No Radiologist Who Was Ever Taken Seriously)
Whether it comes in the form of seemingly extraneous addendums or the need to emphasize key points in radiology reporting, repetition can be a constant source of frustration.
SNMMI: Preliminary Research Suggests Dual-Targeting Radiopharmaceutical May Have Impact in Multiple Cancers
The dual-targeted 177Lu-DOTA-FAPI-RGD reportedly reduced or stopped the growth of cancer lesions in 88.9 percent of advanced adenocarcinomas in a small cohort of patients with varied cancers including pulmonary, pancreatic and ovarian cancer, according to new research presented at the SNMMI conference.
